iZafe Group AB (OSTO:IZAFE B) Notes Receivable : kr0.00 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is iZafe Group AB Notes Receivable?

iZafe Group AB's Notes Receivable for the quarter that ended in Mar. 2025 was kr0.00 Mil.

iZafe Group AB Notes Receivable Historical Data

The historical data trend for iZafe Group AB's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iZafe Group AB Notes Receivable Chart

iZafe Group AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Notes Receivable

Get a 7-Day Free Trial

iZafe Group AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Notes Receivable	Get a 7-Day Free Trial															-	-	-	-	-

iZafe Group AB Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

iZafe Group AB Notes Receivable Related Terms

Thank you for viewing the detailed overview of iZafe Group AB's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

iZafe Group AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iZafe Group AB (OSTO:IZAFE B) » Definitions » Notes Receivable

Comparable Companies

Traded in Other Exchanges

M02:Germany

Address

David Bagares Gata 3, Stockholm, SWE, 111 38

Website

https://www.izafe.se

iZafe Group AB is a pure Life-Science company engaged in the development of digital drug dispensing. The company conducts research, development and marketing of digital medical solutions and services for safer drug management at home. iZafe's drug robot Dosell is used to reduce the risk of incorrect medication at home, relieve public care, increase the patient's quality of life and create a safer environment for relatives. The customers consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe sells through well-established partners who already have long and deep customer relationships with the priority customer groups.

iZafe Group AB Headlines

No Headlines